Novartis Pharmaceuticals Australia Pty Ltd
What they do
Novartis Pharmaceuticals Australia Pty Ltd supplies pharmaceuticals, including CAR T cell therapies such as Kymriah and Tisagenlecleucel, Zolgensma, clinical consumables and items for the National Medical Stockpile.
Who buys from them
South Metropolitan Health Service is the largest buyer with 4 contracts, followed by HealthShare NSW, METRO NORTH HOSPITAL & HEALTH SERVICE, SA Health and Department of Health, Disability and Ageing. It has 5 buyers.
Contract size
Contracts are usually around $550K, with most between $404K and $9.2M. The largest are Tisagenlecleucel CAR T cell therapy at $33.8M for South Metropolitan Health Service, Zolgensma at $11.1M for SA Health and Kymriah CAR T-cell therapy at $9.2M for South Metropolitan Health Service.
Recent activity
2 contracts are active now. The latest award was Mar 2025.
What they win
How much they win each year, the size of a typical contract, and every contract on record.
Contract history
Who they win it from
Their biggest government buyers and how much of their work each one is.
Most of their work comes from one buyer: South Metropolitan Health Service, 75% of value.
Coming up
Contracts that end soon and may go back out to tender.
The next one ends February 2027 at QLD Health.
Recompete radar
1 expiring in 12moContracts nearing the end of their term. Some may go back out to tender when they expire.
About them
Company details, where they work and the names they trade under.
Also traded asNovartis Pharmaceutical Australia Pty Ltd, NOVARTIS PHARMACEUTICALS AUST P/L, Novartis Pharmaceuticals Australia, Novartis Pharmaceuticals Australia Pty Ltd
Similar suppliers
Open tenders that match their work
GovMarket
We do the hard work.
You win the work.
We find the tenders, read the documents and track who wins, so your time goes on bids you can win.
